Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-08

Clinical Trial Update: Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis [NA]

View source ↗

Summary

A completed pediatric trial evaluated an emollient containing postbiotic Saccharomyces and Lactobacillus for atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Postbiotic emollient containing Saccharomyces and Lactobacillus

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Atopic Dermatitis, Eczema | NA | Status: COMPLETED